In Elections’ Wake, New Senate Leadership and a New GAO Study on 340B

by Admin | November 5, 2014 2:02 pm

November 5, 2014—U.S. Senate committees with responsibility for the 340B drug discount program will have new leaders starting early next year following the GOP’s strong showing in yesterday’s midterm elections.  

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

 

 

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2014/11/in-elections-wake-new-senate-leadership-and-a-new-gao-study-on-340b/

Copyright ©2026 340binformed.org unless otherwise noted.